Works matching IS 23265191 AND DT 2025 AND VI 77 AND IP 4
Results: 25
Target Trial Emulations of Sodium‐Glucose Cotransporter 2 Inhibitors in Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 390, doi. 10.1002/art.43130
- By:
- Publication type:
- Article
Joseph D. Croft Jr, MD, 1936‐2024.
- Published in:
- 2025
- By:
- Publication type:
- Obituary
Understanding Late‐Onset Interstitial Lung Disease in Systemic Sclerosis: Implications for Clinical Practice and Trial Design.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 380, doi. 10.1002/art.43053
- By:
- Publication type:
- Article
Characterization of Incident Interstitial Lung Disease in Late Systemic Sclerosis.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 450, doi. 10.1002/art.43051
- By:
- Publication type:
- Article
Macrophage Activation Syndrome.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 367, doi. 10.1002/art.43052
- By:
- Publication type:
- Article
Recommendations for Aligned Nomenclature of Peripheral Nervous System Disorders Across Rheumatology and Neurology.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 383, doi. 10.1002/art.43050
- By:
- Publication type:
- Article
Characterizing Nonarticular Pain at Early Rheumatoid Arthritis Diagnosis: Evolution Over the First Year of Treatment and Impact on Remission in a Prospective Real‐World Early Rheumatoid Arthritis Cohort.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 405, doi. 10.1002/art.43049
- By:
- Publication type:
- Article
Reply.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 492, doi. 10.1002/art.43031
- By:
- Publication type:
- Article
A Strong Dysregulated Myeloid Component in the Epigenetic Landscape of Systemic Sclerosis: An Integrated DNA Methylome and Transcriptome Analysis.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 439, doi. 10.1002/art.43044
- By:
- Publication type:
- Article
Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 395, doi. 10.1002/art.43042
- By:
- Publication type:
- Article
Trends in New Use of Disease‐Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 468, doi. 10.1002/art.43041
- By:
- Publication type:
- Article
Incidence and Genetic Risk of Juvenile Idiopathic Arthritis in Norway by Latitude.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 458, doi. 10.1002/art.43040
- By:
- Publication type:
- Article
FoxO1 Deficiency in Monocytic Myeloid‐Derived Suppressor Cells Exacerbates B Cell Dysfunction in Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 423, doi. 10.1002/art.43046
- By:
- Publication type:
- Article
Reply.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 493, doi. 10.1002/art.43033
- By:
- Publication type:
- Article
Reply.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 490, doi. 10.1002/art.43023
- By:
- Publication type:
- Article
Osteoarthritis: Magnetic resonance imaging definitions and disease progression: comment on the article by Chang et al.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 490, doi. 10.1002/art.43022
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 1, doi. 10.1002/art.42881
- Publication type:
- Article
Clinical Images: A rare and misleading condition: isolated skeletal involvement of Erdheim–Chester disease.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 495, doi. 10.1002/art.43039
- By:
- Publication type:
- Article
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 477, doi. 10.1002/art.43038
- By:
- Publication type:
- Article
Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients With Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population‐Based Target Trial Emulation
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 414, doi. 10.1002/art.43037
- By:
- Publication type:
- Article
Role of autoantibodies in lupus nephritis: comment on the article by Fava et al.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 493, doi. 10.1002/art.43035
- By:
- Publication type:
- Article
Incorrect about International Classification of Diseases coding for patients with systemic lupus erythematosus: comment on the article by Haukeland et al.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 491, doi. 10.1002/art.43025
- By:
- Publication type:
- Article
Clinical Connections.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 1, doi. 10.1002/art.42882
- Publication type:
- Article
Journal Club.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 1, doi. 10.1002/art.42880
- Publication type:
- Article
Issue Information.
- Published in:
- Arthritis & Rheumatology, 2025, v. 77, n. 4, p. 1, doi. 10.1002/art.42879
- Publication type:
- Article